Mesothelin as a Potential Therapeutic Target in Human Cholangiocarcinoma

Background: Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) are the two most common primary liver cancers, yet there have been no significant advances in effective therapeutics. Mesothelin has been reported as a new therapeutic target in various types of cancer. Here, we investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Liping, Feng, Mingqian, Kim, Heungnam, Phung, Yen, Kleiner, David E., Gores, Gregory J., Qian, Min, Wang, Xin Wei, Ho, Mitchell
Formato: Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2010
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948219/
https://www.ncbi.nlm.nih.gov/pubmed/20922056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948219/
https://www.ncbi.nlm.nih.gov/pubmed/20922056

Ejemplares similares